Repositioning Candidate Details
| Candidate ID: | R1265 |
| Source ID: | DB09247 |
| Source Type: | withdrawn |
| Compound Type: | small molecule |
| Compound Name: | Iproclozide |
| Synonyms: | Iproclozide |
| Molecular Formula: | C11H15ClN2O2 |
| SMILES: | CC(C)NNC(=O)COC1=CC=C(Cl)C=C1 |
| Structure: |
|
| DrugBank Description: | Iproclozide is an irreversible and selective hydrazine class based monoamine oxidase inhibitor (MAOI). Although it was employed as an antidepressant for a time, the fact that the agent is capable of causing fulminant hepatitis and that its use has been documented as the cause for at least three reported fatalities has resulted ultimately in the agent being discontinued. |
| CAS Number: | 3544-35-2 |
| Molecular Weight: | 242.7 |
| DrugBank Indication: | For the treatment of depression. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
